Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Join | Sign in
Home>Products>Product Directory>Columns
  Product Directory
Columns

C18 nec (23%) 2mL/200mg
Greyhound Chromatography - Products
C18 nec (23%) 2mL/50mg
Greyhound Chromatography - Products
C18 nec (23%) 300mg
Greyhound Chromatography - Products
C18 nec (23%) 3mL/200mg
Greyhound Chromatography - Products
C18 nec (23%) 3mL/500mg
Greyhound Chromatography - Products
C18 nec (23%) 600mg
Greyhound Chromatography - Products
C18 nec (23%) 6mL/1g
Greyhound Chromatography - Products
C18 nec (23%) 6mL/2g
Greyhound Chromatography - Products
C18 nec (23%) 6mL/500mg
Greyhound Chromatography - Products
C18 nec (23%) 900mg
Greyhound Chromatography - Products
<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 95
Scientific News
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Grant will Help Develop More Powerful Disinfectants
$200,000 grant awarded to develop the next generation of antibacterial cleansers and disinfectants.
Artificially-intelligent Robot Scientist ‘Eve’ Could Boost Search for New Drugs
Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface.
Novogen Announces Important Discovery in Regenerative Medicine Program
A key proof-of-concept step to develop drugs capable of stimulating the function of brain tissue stem cells.
Stanford Chemists Take Step Toward Solving Mystery of How Enzymes Work
Steven Boxer and his students have found that the electrostatic field within an enzyme accounts for the lion's share of its success.
New Class of Synthetic Molecules Mimics Antibodies
A Yale University lab has crafted the first synthetic molecules that have both the targeting and response functions of antibodies.
The Hunt for Botanicals
Herbal medicine can be a double-edged sword and should be more rigorously investigated for both its beneficial and harmful effects, say researchers writing in a special supplement of Science.
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Barrier-Breaking Drug May Lead to Spinal Cord Injury Treatments
NIH-funded scientists take first step towards developing promising new drug.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters